Clinical trial
Personal Genomics: A Safety Study Assessing the Effects of Receiving Genome Sequencing Results
NCT01692223 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personal Genomics: A Safety Study Assessing the Effects of Receiving Genome Sequencing Results
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- August 31, 2018
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
history of cancer